91748-02-6Relevant articles and documents
Protein–ligand interaction-guided discovery of novel VEGFR-2 inhibitors
Zhang, Yanmin,Zhang, Mingliang,Wang, Yuchen,Fan, Yuanrong,Chen, Xingye,Yang, Yan,Hua, Yi,Xie, Wuchen,Lu, Tao,Tang, Weifang,Chen, Yadong,Liu, Haichun
, p. 2559 - 2574 (2020)
As an effective target in abnormal angiogenesis-related tumor treatment, VEGFR-2 has small-molecule inhibitors of various scaffolds being approved for treating diseases such as renal carcinoma, non-small cell lung cancer, etc. However, endogenous and acqu